The SISAQOL-IMI consortium, co-led by the European Organisation for Research and Treatment of Cancer (EORTC) and Boehringer Ingelheim (BI), just announced the publication of its pivotal paper in The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback